文献速递支持与姑息治疗

老年癌症患者100天早期死亡风险评分系统的开发与验证

Predicting early death in older adults with cancer.
PubMed 文献 · Eur J Cancer · 2018-06-29

独立预测因素包括转移性肿瘤、步速<0.8 m/s、MNA<17、MNA≤23.5且≥17、PS>2及非乳腺癌,评分0-6分、7-8分、9-10分、11分对应的100天死亡风险分别为4%、24%、39%、67%。

要点

  • 该评分可协助老年癌症患者的治疗决策
  • 营养状态(MNA)是权重最高的预测因素
  • 评分11分者100天死亡风险达67%

核心结论

  • 开发了首个用于估计老年癌症患者早期死亡的评分系统,可辅助治疗决策。

主要发现

  • 独立预测因素为转移性肿瘤(OR 2.5;95%CI 1.7-3.5;p<0.001)、步速<0.8 m/s(OR 2.1;95%CI 1.3-3.3;p=0.001)、MNA<17(OR 8;95%CI 3.7-17.3;p<0.001)、MNA≤23.5且≥17(OR 4.4;95%CI 2.1-9.1;p<0.001)、PS>2(OR 1.7;95%CI 1.1-2.6;p=0.015)及非乳腺癌(OR 4;95%CI 2.1-7.9;p<0.001)。
  • 100天死亡风险:0-6分为4%,7-8分为24%,9-10分为39%,11分为67%。

关键数值与推荐

  • 赋分:MNA<17为4分,MNA≤23.5且≥17为3分,转移性肿瘤为2分,步速<0.8 m/s为1分,PS>2为1分,非乳腺癌为3分。

临床怎么用

  • 在治疗决策前对70岁以上癌症患者完成CGA并计算该评分,依据分层风险辅助制定治疗策略。

局限性

  • 仅进行内部验证(bootstrap法),未报告外部验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Predicting early death after a comprehensive geriatric assessment (CGA) is very difficult in clinical practice. The aim of this study was to develop a scoring system to estimate risk of death at 100 days in elderly cancer patients to assist the therapeutic decision. METHODS: This was a multicentric, prospective cohort study approved by an ethics committee. Elderly cancer patients aged older than 70 years were enrolled before the final therapeutic decision. A standardised CGA was made before the treatment decision at baseline. Within 100 days, event (death), oncologic and geriatric data were collected. Multivariate logistic regression was used to select the risk factors for the overall population. Score points were assigned to each risk factor using the β coefficient. Internal validation was performed by a bootstrap method. Calibration was assessed with the Hosmer-Lemeshow goodness of fit test and accuracy with the mean c-statistic. FINDINGS: One thousand fifty patients (mean age: 82 years) joined the study from April 2012 to December 2014. The independent predictors were metastatic cancers (odds ratio [OR] 2.5; 95% confidence interval [CI], [1.7-3.5] p<0 .001); gait speed<0.8 m/s (OR 2.1; 95% CI [1.3-3.3] p=0.001); Mini Nutritional Assessment (MNA) < 17 (OR 8; 95% CI; [3.7-17.3] p<0.001), MNA ≤23.5 and ≥ 17 (OR 4.4; 95% CI, [2.1-9.1) p<0.001); performance status (PS) > 2 (OR 1.7; 95% CI, [1.1-2.6)] p=0.015) and cancers other than breast cancer (OR 4; 95% CI, [2.1-7.9] p<0.001). We attributed 4 points for MNA<17, 3 points for MNA between ≤23.5 and ≥ 17, 2 points for metastatic cancers, 1 point for gait speed <0.8 m/s, 1 point for PS > 2 and 3 points for cancers other than breast cancer. The risk of death at 100 days was 4% for 0 to 6 points, 24% for 7 to 8 points, 39% for 9 to 10 points and 67% for 11 points. INTERPRETATION: To our knowledge, this is the first score which estimates early death in elderly cancer patients. The system could assist in the treatment decision for elderly cancer patients.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Boulahssass R, Gonfrier S, Ferrero JM, et al. Predicting early death in older adults with cancer. Eur J Cancer. 2018. PMID: 30014882. doi:10.1016/j.ejca.2018.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。